Focused on Pharmaceutical Impact

KineMed's TM and PM platform has enormous potential impact on the successful creation of best-in-class medicines. In the decade we have spent developing and working with the platform with over a dozen pharmaceutical partners, it has proven to have very powerful, specific applications in the pursuit of medicines to prevent or treat diseases across a broad range of therapy areas.

Powerful Insights into Health, Disease, and Drug Action

• Cardiovascular and metabolic diseases: obesity, pre-diabetes / metabolic syndrome, diabetes and atherosclerosis
• Nervous system diseases: neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Lou Gehrig's disease; diseases involving deficient neurogenesis such as cognitive and mood disorders; and diseases involving neuroinflammation such as multiple sclerosis
• Cellular proliferation diseases: including cancers, psoriasis
• Connective tissue and musculo-skeletal diseases: fibrotic diseases such as cirrhosis, idiopathic pulmonary fibrosis, scleroderma, COPD, osteoporosis, osteoarthritis, rheumatoid arthritis and muscle wasting
• Inflammatory and endocrine diseases and related pharmacology: characterization of selective glucocorticoid receptor modulators, selective androgen or estrogen receptor modulators